miR Scientific Noninvasive Prostate Cancer Test Validation Published
miR Scientific’s urine-based, noninvasive cancer test can detect molecular evidence of prostate cancer with sensitivity of 94% and specificity of 92%.
Read More
Search Results for: point-of-care
Blood Test May Point to Higher Risk for Covid-19 Death
Elevated levels of these five biomarkers were associated with inflammation and bleeding disorder as well as increased risk of death in covid-19 patients.
Read More
Sight Diagnostics Expanding Fingerstick CBC Testing
The Israeli company behind the first FDA-cleared direct-from-fingerstick CBC analyzer plans to expand its operations in the United States.
Read More
Fujirebio Begins Testing for Fully Automated SARS-CoV-2 Antigen Assay
Fujirebio Diagnostics has begun the clinical testing of its new SARS-CoV-2 antigen assay with the goal of providing the first fully automated antigen test.
Read MoreHHS Details New Covid-19 Testing Statistics Amid Test Volume Surge
More than 59 million covid-19 tests have now been completed nationally—averaging more 810,000 per day over the previous 7 days.
Read More